Akoya Biosciences Inc (AKYA)
2.85
-0.05
(-1.72%)
USD |
NASDAQ |
May 17, 16:00
2.85
0.00 (0.00%)
After-Hours: 20:00
Akoya Biosciences Cash from Financing (Quarterly): -0.444M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -0.444M |
December 31, 2023 | 11.08M |
September 30, 2023 | -0.141M |
June 30, 2023 | 46.33M |
March 31, 2023 | -0.419M |
December 31, 2022 | 10.27M |
September 30, 2022 | 9.86M |
June 30, 2022 | 8.667M |
March 31, 2022 | -0.071M |
Date | Value |
---|---|
December 31, 2021 | 0.149M |
September 30, 2021 | -0.044M |
June 30, 2021 | 136.93M |
March 31, 2021 | -0.004M |
December 31, 2020 | 5.687M |
September 30, 2020 | 0.04M |
June 30, 2020 | 2.419M |
March 31, 2020 | -2.66M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-2.66M
Minimum
Mar 2020
136.93M
Maximum
Jun 2021
13.39M
Average
0.149M
Median
Dec 2021
Cash from Financing (Quarterly) Benchmarks
Azenta Inc | -74.07M |
Harvard Bioscience Inc | -1.055M |
Standard BioTools Inc | -19.73M |
Bionano Genomics Inc | -21.62M |
Singular Genomics Systems Inc | 0.00 |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -20.82M |
Cash from Investing (Quarterly) | -48.82M |
Free Cash Flow | -55.62M |
Free Cash Flow Per Share (Quarterly) | -0.4398 |
Free Cash Flow to Equity (Quarterly) | -21.85M |
Free Cash Flow to Firm (Quarterly) | -19.95M |
Free Cash Flow Yield | -41.42% |